LCM
TMO icon

Logan Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Logan Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-362
Closed -$196K – 504
2025
Q4 		$210K Hold
362
– – 0.01% 272
2025
Q3 		$176K Hold
362
– – 0.01% 278
2025
Q2 		$147K Hold
362
– – 0.01% 274
2025
Q1 		$180K Sell
362
-29
-7% -$15.7K 0.01% 284
2024
Q4 		$203K Buy
391
+3
+0.8% +$1.65K 0.01% 283
2024
Q3 		$240K Buy
388
+6
+2% +$3.55K 0.01% 278
2024
Q2 		$211K Hold
382
– – 0.01% 283
2024
Q1 		$222K Sell
382
-13
-3% -$7.29K 0.01% 280
2023
Q4 		$210K Sell
395
-120
-23% -$58.1K 0.01% 287
2023
Q3 		$261K Sell
515
-1
-0.2% -$533 0.01% 270
2023
Q2 		$269K Sell
516
-107
-17% -$57.7K 0.01% 267
2023
Q1 		$359K Sell
623
-20
-3% -$11.3K 0.02% 267
2022
Q4 		$354K Hold
643
– – 0.02% 263
2022
Q3 		$326K Sell
643
-23
-3% -$12.9K 0.02% 257
2022
Q2 		$362K Sell
666
-16
-2% -$8.81K 0.02% 257
2022
Q1 		$403K Hold
682
– – 0.02% 259
2021
Q4 		$455K Buy
682
+228
+50% +$142K 0.02% 258
2021
Q3 		$259K Buy
454
+23
+5% +$12.6K 0.01% 279
2021
Q2 		$217K Buy
431
+20
+5% +$9.44K 0.01% 280
2021
Q1 		$188K Buy
+411
New +$196K 0.01% 281

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Logan Capital Management's TMO Position: Q1 2026 in Review

Logan Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 362 shares — an estimated $196K sold.

Logan Capital Management first reported a position in TMO in Q1 2021 and held it in 20 quarters. The position peaked at $455K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Logan Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 362 Thermo Fisher Scientific shares in Q1 2026, an estimated $196K.
  • Logan Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 20 quarters.
  • Logan Capital Management's Thermo Fisher Scientific position peaked at $455K in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.